It is also important to note that formoterol is a potent β2-AR agonist, and research by McCulloch et al. has revealed that adrenergic signaling, triggered by the surge in sympathetic activity after stroke, decreases the number of B cells in the periphery and contributes to post-stroke immunosuppression [42]. This evidence concerns the gene ADRB2 and stroke disorder.